StreetInsider.com News Articles

Harvard Bioscience forms scientific advisory board with four members

Tue, 06 Oct 2026 16:05:11 -0400

Harvard Bioscience, Inc. (Nasdaq: HBIO) announced the formation of a Scientific Advisory Board (SAB) to guide the company's research, development, and product roadmaps, according to a press release.

The SAB will meet quarterly and consists of five members, including President and CEO John Duke and four external industry figures.

The four outside members appointed to the board are:

Dr. Ryan Conder, Director of Epithelial and Organoid Systems at STEMCELL Technologies and adjunct professor at Simon Fraser University.

Dr. Aaron Goldman, founder and Director of the Drug Resistance Group at Brigham and Women's Hospital, with appointments at Dana-Farber Cancer Institute, Harvard Medical School, and Mass

Harvard Bioscience Announces Creation of Scientific Advisory Board

Tue, 06 Oct 2026 16:05:00 -0400

HOLLISTON, Mass., Oct. 06, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced the creation of its Scientific Advisory Board (SAB) to guide the Company’s ongoing research, development, and new product roadmaps. The SAB will meet quarterly and consists of five members, Harvard Bioscience President and CEO John Duke and four experienced industry leaders.

"The formation of our Scientific Advisory Board marks an exciting chapter for Harvard Bioscience," said John Duke, President and CEO of Harvard Bioscience. "It brings together distinguished industry leaders to influence our R&D and new product roadmaps. The combined expertise in

Harvard Bioscience Announces Creation of Scientific Advisory Board

Tue, 06 Oct 2026 16:05:00 -0400

Form SCHEDULE 13G/A HARVARD BIOSCIENCE INC Filed by: Leviticus Partners LP

Tue, 22 Sep 2026 10:21:00 -0400

si-local-file:///var/storage/secattach/20260922/27089356.html

Harvard Bioscience (HBIO) PT Raised to $7.50 at Benchmark on Q2 Beat and Raise

Wed, 12 Aug 2026 08:56:11 -0400

Benchmark analyst Bruce Jackson raised the price target on Harvard Bioscience Inc. (NASDAQ: HBIO) to $7.50 (from $6.00) while maintaining a Speculative Buy rating.

The analyst commented, "Harvard Bioscience 2Q revenue of $22.7 million exceeded the management guidance range of $20.5-22.5 million and the $21.5 million consensus estimate. The company raised its full-year 2026 revenue growth guidance to 3-5% (was 2- 4%), while lowering its adjusted gross margin target to 57-59% (was 58-60%), and reaffirmed Adjusted EBITDA growth of 6- 10%. Management introduced 3Q guidance for revenue of $21.0-22.6 million with Adjusted gross margins of 56-58% and Adjusted EBITDA of $1.5-2.5

Harvard Bioscience (HBIO) PT Raised to $7.50 at Benchmark on Q2 Beat and Raise

Wed, 12 Aug 2026 08:56:11 -0400

Benchmark analyst Bruce Jackson raised the price target on Harvard Bioscience Inc. (NASDAQ: HBIO) to $7.50 (from $6.00) while maintaining a Speculative Buy rating.

Form 10-Q HARVARD BIOSCIENCE INC For: Jun 30

Tue, 11 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260811/26906355.html

Form 10-Q HARVARD BIOSCIENCE INC For: Jun 30

Tue, 11 Aug 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260811/26906355.html

Harvard Bioscience (HBIO) Tops Q2 EPS by 24c ; Offers Guidance

Tue, 11 Aug 2026 07:42:30 -0400

Harvard Bioscience (NASDAQ: HBIO) reported Q2 EPS of ($0.14), $0.24 better than the analyst estimate of ($0.38). Revenue for the quarter came in at $22.73 million versus the consensus estimate of $21.9 million.

Q3 2026 Outlook:-

Revenue between $21.0 million and $22.6 million vs consensus $21.85 million.

For earnings history and earnings-related data on Harvard Bioscience (HBIO) click here.

Form 8-K HARVARD BIOSCIENCE INC For: Aug 11

Tue, 11 Aug 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260811/26901174.html

Form 8-K HARVARD BIOSCIENCE INC For: Aug 11

Tue, 11 Aug 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260811/26901174.html

Form 8-K HARVARD BIOSCIENCE INC For: Aug 11

Tue, 11 Aug 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260811/26901180.html

Form 8-K HARVARD BIOSCIENCE INC For: Aug 11

Tue, 11 Aug 2026 07:01:00 -0400

si-local-file:///var/storage/secattach/20260811/26901180.html

Harvard Bioscience Announces Second Quarter 2026 Financial Results

Tue, 11 Aug 2026 07:00:00 -0400

Second Quarter 2026 Revenue Growth of 11% Year Over Year to $22.7 Million
Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth

HOLLISTON, Mass., Aug. 11, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company” or “Harvard Bioscience”) today announced financial results for the second quarter ended June 30, 2026.

"We delivered a strong quarter anchored by 11% top-line growth, reflective of stronger demand and an improved environment across our key customer channels,” said John Duke, President and Chief Executive Officer. “We are seeing solid commercial

Harvard Bioscience Announces Second Quarter 2026 Financial Results

Tue, 11 Aug 2026 07:00:00 -0400

Second Quarter 2026 Revenue Growth of 11% Year Over Year to $22.7 Million
Raises Full Year 2026 Revenue Guidance to 3%-5% Year Over Year Growth

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Tue, 28 Jul 2026 07:30:00 -0400

HOLLISTON, Mass., July 28, 2026 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended June 30, 2026, before the market opens on August 11, 2026, and will hold a conference call to discuss the results at 8:00 a.m. Eastern Time.

Analysts who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.

Participants who would like to join the audio-only webcast should go to our events and presentations

Harvard Bioscience Schedules Second Quarter 2026 Earnings Conference Call for August 11, 2026 at 8:00 AM ET

Tue, 28 Jul 2026 07:30:00 -0400

Analysts who would like to join the call and ask a question must register here. Once registered, you will receive the dial-in numbers and a unique PIN number.

Participants who would like to join the audio-only webcast should go to our events and presentations

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Eade Katherine A.

Fri, 12 Jun 2026 11:52:00 -0400

si-local-file:///var/storage/secattach/20260612/26639498.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Eade Katherine A.

Fri, 12 Jun 2026 11:52:00 -0400

si-local-file:///var/storage/secattach/20260612/26639498.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Snider William

Thu, 11 Jun 2026 12:56:00 -0400

si-local-file:///var/storage/secattach/20260611/26634705.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Snider William

Thu, 11 Jun 2026 12:56:00 -0400

si-local-file:///var/storage/secattach/20260611/26634705.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: DENELSKY STEPHEN J

Thu, 11 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26633859.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: DENELSKY STEPHEN J

Thu, 11 Jun 2026 10:03:00 -0400

si-local-file:///var/storage/secattach/20260611/26633859.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Gagnon Robert E.

Thu, 11 Jun 2026 10:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26633854.html

Form 4 HARVARD BIOSCIENCE INC For: Jun 09 Filed by: Gagnon Robert E.

Thu, 11 Jun 2026 10:02:00 -0400

si-local-file:///var/storage/secattach/20260611/26633854.html